Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04368533 · ClinicalTrials.gov registry record · Phase 1
Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 78
- Enrollment target
NCT04368533 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 78 participants.
The verdict
NCT04368533, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 78 participants
- Enrollment target
Study Summary
This is an investigator initiated randomized double-blind pilot study at the UCSF Pediatric Dental Clinics to compare effectiveness of a new toothpaste Livionex Dental Gel with a standard children's toothpaste containing 1500 ppm fluoride in reducing dental plaque and caries in healthy and well children every 3 months for up to 12 months.
Interventions
- DRUG Livionex Dental Gel
- DRUG A standard children's toothpaste containing 1500 ppm fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2020-08-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04368533
The ClinicalTrials.gov registry entry for NCT04368533 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Livionex Dental Gel is the first listed.
NCT04368533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04368533 about?
NCT04368533 is a clinical study titled "Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children". This is an investigator initiated randomized double-blind pilot study at the UCSF Pediatric Dental Clinics to compare effectiveness of a new toothpaste Livionex Dental Gel with a standard children's toothpaste containing 1500 ppm fluoride in reducing dental plaque and caries in healthy and well chil...
What is the current status of trial NCT04368533?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2019-02-08. Estimated completion is 2020-08-21.
What interventions are being tested in trial NCT04368533?
The interventions under investigation include: Livionex Dental Gel (DRUG), A standard children's toothpaste containing 1500 ppm fluoride (DRUG).
Who is sponsoring clinical trial NCT04368533?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.